Comparative study of statinsanddifferent formulation of statins- a review

×

Error message

  • User warning: The following theme is missing from the file system: journalijdr. For information about how to fix this, see the documentation page. in _drupal_trigger_error_with_delayed_logging() (line 1138 of /home2/journalijdr/public_html/includes/bootstrap.inc).
  • Deprecated function: implode(): Passing glue string after array is deprecated. Swap the parameters in drupal_get_feeds() (line 394 of /home2/journalijdr/public_html/includes/common.inc).
  • Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in _menu_load_objects() (line 579 of /home2/journalijdr/public_html/includes/menu.inc).

International Journal of Development Research

Volume: 
7
Article ID: 
8525
9 pages
Review Article

Comparative study of statinsanddifferent formulation of statins- a review

Dr. Pathak, D.P. and Akanksha

Received 29th April, 2017; Received in revised form 24th May, 2017; Accepted 16th June, 2017; Published online 22nd July, 2017

Copyright©2017, Dr. Pathak and Akanksha. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract: 

Statins are very commonly used antihyperlipidaemic in all over theworld. Statins are the main API occurred in all antihyperlipidaemic drugs. This classes of compounds are the most efficacious and the best tolerated hypolipidaemic drugs. Statins reduced the raised LDL-CH associated mortality and morbidity is now established. Up to certain therapeutic dose is useful but anoverdose of Statins start side effects like a headache, Nausea, vomiting and bowel upset, rashes on the body. This review aims at compiling the research inputs being made for developing therapeutically efficacious dosage forms that have the potential to surmount the limitations of conventional dosage of statins.

Download PDF: 
PDF icon 8525.pdf